Actively Recruiting

Age: 18Years +
All Genders
ID06782100

MRI Guided Management of Occlusive Peripheral Arterial Disease

Led by The Methodist Hospital Research Institute · Updated on 2026-03-19

175

Participants Needed

1

Research Sites

47 weeks

Total Duration

On this page

Sponsors

T

The Methodist Hospital Research Institute

Lead Sponsor

N

National Heart, Lung, and Blood Institute (NHLBI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are studying peripheral arterial disease (PAD) to identify which plaque lesions are impenetrable and to find out which devices cause the least injury to the vessel walls. This observational study includes patients undergoing percutaneous vascular intervention (PVI) and patients undergoing lower limb amputation due to PAD. The study aims to improve understanding of plaque types and their impact on treatment success. Participants in the study will undergo MRI scans before their planned PVI to assess the plaque and predict procedural difficulty. For patients undergoing lower limb amputation, the removed limbs will also receive MRI scans to assess plaques. The study compares two devices, plain balloon angioplasty (POBA) and orbital atherectomy, in amputated limbs to evaluate their effects on the vessel wall and device safety. Plaques are categorized into four types based on MRI-histology: concentric calcium, eccentric calcium, fibrous plaque, and soft plaques. During the study, 100 patients will have scans using a 3T MAGNETOM MRI scanner. Doctors performing the PVI will not see the MRI results and will treat patients according to standard care. Researchers will analyze which plaques predict procedural failures and the need for additional devices or approaches. Outcomes will be measured during the procedure and through histological evaluation of amputated limbs. The study lasts until June 2029 and involves detailed imaging and histological assessments to improve PAD management.

CONDITIONS

Brief Title

MRI Guided Management of Occlusive Peripheral Arterial Disease

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 18 years or older with peripheral arterial disease at Rutherford category 4, 5, or 6
  • At least one target lesion below the knee in native vessels
  • Target lesion reference vessel diameter between 2.0 and 4.0 millimeters by visual estimate
  • Target lesion with more than 50% stenosis by visual estimate
Not Eligible

You will not qualify if you...

  • Patients with Rutherford category 0, 1, 2, or 3 of the target limb
  • Failure or refusal to provide written informed consent
  • Contraindications to MRI
  • For the amputation arm only: chronic total occlusions

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - 1 day

Participants undergo MRI scans using optimized sequences to characterize plaque types and score lesions before any treatment.

1 imaging visit (in-person)

Monitoring

Duration - Intraprocedural

Participants who undergo standard peripheral vascular interventions are observed to assess procedure outcomes without alteration to their treatment.

During the procedure

Trial Site Locations

Total: 1 location

1

Houston Methodist Hospital

Houston, Texas, United States, 77030

Actively Recruiting

Loading map...

Research Team

T

Trisha Roy, MD, PhD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

A Contrast Medium Sparing Strategy Using Automated Carbon Di...

Peripheral Vascular Diseases

Actively Recruiting

11 locations

Drug-Eluting Registry: Real-World Treatment of Lesions in th...

Peripheral Vascular Diseases

Actively Recruiting

79 locations

Examining the Impact of Exercise Training on Vascular Dysfun...

Peripheral Vascular Diseases

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Automatic Classification of Magnetic Resonance Histology of Peripheral Arterial Chronic Total Occlusions Using a Variational Autoencoder: A Feasibility Study.

Judit Csore, Christof Karmonik, Kayla Wilhoit...

https://pubmed.ncbi.nlm.nih.gov/37296778

Optimal Vessel Sizing and Understanding Dissections in Infrapopliteal Interventions: Data From the iDissection Below the Knee Study.

Nicolas W Shammas, W John Shammas, Susan Jones-Miller...

https://pubmed.ncbi.nlm.nih.gov/32419593

Impact of Prolonged Inflation Times During Plain Balloon Angioplasty on Angiographic Dissection in Femoropopliteal Lesions.

Kazunori Horie, Akiko Tanaka, Masataka Taguri...

https://pubmed.ncbi.nlm.nih.gov/30203701

Derivation and validation of the J-CTO extension score for pre-procedural prediction of major adverse cardiac and cerebrovascular events in patients with chronic total occlusions.

Soichiro Ebisawa, Shun Kohsaka, Toshiya Muramatsu...

https://pubmed.ncbi.nlm.nih.gov/32915843

Diagnostic confidence of run-off CT-angiography as the primary diagnostic imaging modality in patients presenting with acute or chronic peripheral arterial disease.

Thomas Werncke, Kristina Imeen Ringe, Christian von Falck...

https://pubmed.ncbi.nlm.nih.gov/25835948

Animal Models of Neointimal Hyperplasia and Restenosis: Species-Specific Differences and Implications for Translational Research.

Max L A Ebert, Vanessa F Schmidt, Lena Pfaff...

https://pubmed.ncbi.nlm.nih.gov/34869956